Showing results (321-330 of 350) with videos related to
Sort By:
Pageof 35
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.Research and Practice in Thrombosis and Haemostasis|August 22, 2022
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarinIngrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf, et al.Clinical Reviews in Allergy & Immunology|March 7, 2025
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and TreatmentBruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.Nature Reviews. Cardiology|March 21, 2024
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal diseaseAzita H Talasaz, Parham Sadeghipour, Luis Ortega-Paz, et al.BMJ (Clinical Research Ed.)|October 15, 2021
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trialMichelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.Nature Reviews. Cardiology|March 11, 2026
Antiphospholipid antibodies and cardiovascular thrombosisSina Rashedi, Hannah Leyva, Saman A Siddiqui, et al.The Journal of Allergy and Clinical Immunology. Global|April 25, 2025
Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitorMarkus Magerl, Marc A Riedl, Luisa Karla Arruda, et al.Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Heparin for Moderately Ill Patients with Covid-19Michelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.Journal of Critical Care|August 3, 2024
Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trialFernando G Zampieri, Glauco Adrieno Westphal, Maria Adelaide Dos Santos, et al.Pageof 35